Julie la Rocca

TVP Management Co. LLC (TVP Management) is a venture capital subsidiary of Grayhawk Capital founded in 2006. The firm is headquartered in Phoenix, Arizona.

Translational Genomics Research Institute operates as non-profit organization. It focuses on developing earlier diagnoses and smarter treatments. Translational research applies to the development of diagnostics, prognostics, and therapies for cancer, neurological disorders, diabetes, and other complex diseases. The company was founded by Jeffrey M. Trent in 2002 and is headquartered in Phoenix, AZ.

Scottsdale Healthcare Corp. provides healthcare services. It identifies healthcare needs for the community. The firm serves the Northeast Valley and beyond through three campuses, three hospitals, outpatient centers, home health services, and a community health education, and outreach programs. The company was founded in 1962 and is headquartered in Scottsdale, AZ.

Medelis, Inc. provides oncology clinical research services. Its services include oncology CRO services, oncology drug development consulting, preclinical development, study design, study launch, study management, medical writing, data management and biostatistics. clinical trials regulatory affairs, and supplemental oncology clinical development services. The company was founded by Daniel Douglas Von Hoff on October 21, 2003 and is headquartered in Nashville, TN.

Mayo Foundation for Medical Education & Research operates as a medical care research and education organization. Its services include patient care, corporate services, research, and education. The company was founded in 1984 and is headquartered in Rochester, MN.

Systems Oncology LLC engages in the development of cancer drug and therapies. It combines multi-scalar systems modeling with machine learning and big-data to uncover breakthrough insights into cancer biology and expose new therapeutic vulnerabilities. The company is headquartered in Scottsdale, AZ.

American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA.

Inform Diagnostics, Inc. provides pathology diagnostic services. It offers subspecialty anatomic pathology in the fields of breast health, dermatology, gastroenterology, hematology, and urology. The company was founded by David D. Halbert and Harold Roe in 1996 and is headquartered in Irving, TX.

Caris Life Sciences Ltd. provides diagnostics and anatomic pathology services. The firm develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring, and precision medicine enabling aspects. It offers services throughout the U.S., Europe, Australia and other international markets. The company was founded by David D. Halbert in 2008 and is headquartered in Irving, TX.

University of Washington functions as a College/University. The company is headquartered in Seattle, WA.

US Oncology, Inc. engages in the provision of cancer care servicers. It offers therapies, depending on such things as type of cancer, stage at diagnosis and the patient’s overall health such as chemotherapy, radiotherapy, surgery, hormone therapy, and immunotherapy. The company was founded in 1999 and is headquartered in The Woodlands, TX.

Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA.

Boston Millennia Partners (BMP) is a private equity and venture capital subsidiary of Glen Ventures Management, Inc founded in 1997 by Dana Callow. The firm headquartered in Boston, Massachusetts.

MedTrust Online LLC develops online support and connection services for oncologists. It provides Internet-based solution that enables physicians to practice precision medicine. The company was founded by Christopher Yoo on December 3, 2007 and is headquartered in Scottsdale, AZ.

Applied Microarrays, Inc. manufactures custom nucleic acid and protein microarrays. The firm’s solutions include disease applications, point-of-care arrays, high throughput and instrumentation. Its services include manufacturing process, array design and optimization and project management. The company was founded by Alastair Malcolm in 2006 and is headquartered in Tempe, AZ.

Salutaris Medical Devices, Inc. operates as a clinical-stage medical device company. It develops minimally invasive, patient-centric treatments. The firm also develops an investigational ophthalmic treatment for Wet Age-related Macular Degeneration (Wet AMD). The company was founded by Russell J. Hamilton and Laurence J. Marsteller in 2008 and is headquartered in Tucson, AZ.

Ascalon International, Inc. develops oncology drugs. The company was founded by Keith Benson on February 24, 2010 and is headquartered in Scottsdale, AZ.

SynDevRx, Inc. develops treatments for metabolic-related diseases. Its product includes SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active small molecule fumagillol derivative in vivo. The company was founded by James M. Shanahan and Bradley J. Carver and is headquartered in Cambridge, MA.

Translational Accelerator LLC seeks investment opportunities in companies located in the US. The fund targets companies operating in the fields of oncology, neuroscience, developing diagnostics, medical tests or services. It provides financing for early stage capital requirements.

The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research.